These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 17122134
1. Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits. Framme C, Sachs HG, Flucke B, Theisen-Kunde D, Birngruber R. Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5437-46. PubMed ID: 17122134 [Abstract] [Full Text] [Related]
2. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6). Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM. Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627 [Abstract] [Full Text] [Related]
3. Clinical evaluation of experimentally induced choroidal neovascularizations in pigmented rabbits by subretinal injection of lipid hydroperoxide and consecutive preliminary photodynamic treatment with Tookad. Framme C, Sachs HG, Kobuch K, Flucke B, Birngruber R. Ophthalmologica; 2008 Jul; 222(4):254-64. PubMed ID: 18525218 [Abstract] [Full Text] [Related]
4. Threshold power levels for NPe6 photodynamic therapy. Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi AA. Ophthalmic Surg Lasers; 2000 Jul; 31(2):136-42. PubMed ID: 10743925 [Abstract] [Full Text] [Related]
5. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes. Berdugo M, Bejjani RA, Valamanesh F, Savoldelli M, Jeanny JC, Blanc D, Ficheux H, Scherz A, Salomon Y, BenEzra D, Behar-Cohen F. Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085 [Abstract] [Full Text] [Related]
6. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion. Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T. Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2639-45. PubMed ID: 11581211 [Abstract] [Full Text] [Related]
7. Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2). Peyman GA, Moshfeghi DM, Moshfeghi A, Khoobehi B, Doiron DR, Primbs GB, Crean DH. Ophthalmic Surg Lasers; 1997 May; 28(5):409-17. PubMed ID: 9150524 [Abstract] [Full Text] [Related]
9. Comparison of reduced and standard light application in photodynamic therapy of the eye in two rabbit models. Framme C, Flucke B, Birngruber R. Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):773-81. PubMed ID: 16440207 [Abstract] [Full Text] [Related]
10. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels. Peyman GA, Kazi AA, Moshfeghi D, Unal M, Khoobehi B, Yoneya S, Mori K, Rivera I. Ophthalmic Surg Lasers; 2000 Jul; 31(4):323-7. PubMed ID: 10928670 [Abstract] [Full Text] [Related]
11. Scanning laser system for photodynamic therapy of choroidal neovascularization. Obana A, Gohto Y. Lasers Surg Med; 2002 Jul; 30(5):370-5. PubMed ID: 12116330 [Abstract] [Full Text] [Related]
12. Mechanism of photodynamic occlusion using liposomal Zn(II)-phtalocyanine. Schmidt-Erfurth U, Michels S, Indorf L, Eggers R, Birngruber R. Curr Eye Res; 2005 Jul; 30(7):601-12. PubMed ID: 16020295 [Abstract] [Full Text] [Related]
13. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2. Renno RZ, Terada Y, Haddadin MJ, Michaud NA, Gragoudas ES, Miller JW. Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365 [Abstract] [Full Text] [Related]
14. Evaluation of photopoint photosensitizer mv6401, indium chloride methyl pyropheophorbide, as a photodynamic therapy agent in primate choriocapillaris and laser-induced choroidal neovascularization. Ciulla TA, Criswell MH, Danis RP, Snyder WJ, Small W. Retina; 2004 Aug; 24(4):521-9. PubMed ID: 15300072 [Abstract] [Full Text] [Related]
15. Threshold determinations for selective retinal pigment epithelium damage with repetitive pulsed microsecond laser systems in rabbits. Framme C, Schuele G, Roider J, Kracht D, Birngruber R, Brinkmann R. Ophthalmic Surg Lasers; 2002 Aug; 33(5):400-9. PubMed ID: 12358294 [Abstract] [Full Text] [Related]
16. Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys. Obana A, Gohto Y, Kanai M, Nakajima S, Kaneda K, Miki T. Arch Ophthalmol; 2000 May; 118(5):650-8. PubMed ID: 10815157 [Abstract] [Full Text] [Related]
17. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6. Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM. Retina; 2001 May; 21(5):499-508. PubMed ID: 11642380 [Abstract] [Full Text] [Related]
18. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization. Zacks DN, Ezra E, Terada Y, Michaud N, Connolly E, Gragoudas ES, Miller JW. Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441 [Abstract] [Full Text] [Related]
19. Experimental photodynamic effects of hypocrellin A on the choriocapillaris. Khoobehi B, Grinstead R, Passos E. Ophthalmic Surg Lasers; 2002 Jul; 33(3):207-13. PubMed ID: 12027100 [Abstract] [Full Text] [Related]
20. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Kramer M, Miller JW, Michaud N, Moulton RS, Hasan T, Flotte TJ, Gragoudas ES. Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419 [Abstract] [Full Text] [Related] Page: [Next] [New Search]